The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy
Jiazhou Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yuxian Wei(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 8
Related Papers
Prostate cancer treatment – China's perspective
|Cancer Letters|2022|99
Identification of cancer-associated fibroblasts subtypes in prostate cancer
|Frontiers in Immunology|2023|43
Reprogramming exosomes for immunity-remodeled photodynamic therapy against non-small cell lung cancer
|Bioactive Materials|2024|41
Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study
|International Journal of Surgery|2024|8